Patents by Inventor Joseph L Glajch

Joseph L Glajch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6455024
    Abstract: Radiotherapy agents which are solid or porous particles are described. The particles are of an inorganic material containing a suitable radionuclide and having an average particle diameter of about 0.05 to 5000 microns.
    Type: Grant
    Filed: April 2, 1999
    Date of Patent: September 24, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Joseph L. Glajch, Prahlad R. Singh
  • Publication number: 20020114763
    Abstract: Radiotherapy agents which are solid or porous particles are described. The particles are of an inorganic material containing a suitable radionuclide and having an average particle diameter of about 0.05 to 5000 microns.
    Type: Application
    Filed: April 2, 1999
    Publication date: August 22, 2002
    Inventors: JOSEPH L. GLAJCH, PRAHLAD R. SINGH
  • Patent number: 6254852
    Abstract: Targeted ultrasound contrast agents are described. The contrast agents are porous particles of an inorganic material containing an entrapped gas or liquid and having an average particle diameter of about 0.05 to 500 microns. The outer surfaces of the particles incorporate a targeting ligand to target delivery of the contrast agent.
    Type: Grant
    Filed: July 16, 1999
    Date of Patent: July 3, 2001
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Joseph L Glajch, Alan P. Carpenter, Jr., Edward H. Cheesman
  • Patent number: 5147631
    Abstract: The invention relates to ultrasound contrast agents comprising porous particles of an inorganic material containing an entrapped gas or liquid and having an average particle diameter of about 0.05 to 500 microns, said inorganic material being selected from one or more of the group consisting of: monomeric or polymeric borates; monomeric or polymeric aluminas; monomeric or polymeric carbonates; monomeric or polymeric silicas; and monomeric or polymeric phosphates; and pharmaceutically acceptable organic or inorganic cationic salts thereof.
    Type: Grant
    Filed: April 30, 1991
    Date of Patent: September 15, 1992
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Joseph L. Glajch, Gary L. Loomis, Walter Mahler
  • Patent number: 4847159
    Abstract: This invention involves unique compositions consisting of substrates coated with organo-silanes that are sterically protected by a single bulky group. This material consists of an appropriate reactive solid to which is attached a silane whose silicon stom is bonded to a functional group that contains a dimethyl-substituted tertiary carbon.
    Type: Grant
    Filed: November 10, 1987
    Date of Patent: July 11, 1989
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Joseph L. Glajch, Joseph J. Kirkland
  • Patent number: 4746572
    Abstract: A bidentate silane containing at least two silicon atoms bridged by certain groups, arranged to form at least a seven member ring system, is formed between the bidentate silane and the atoms to which the silane is covalently attached on the substrate surface.
    Type: Grant
    Filed: November 28, 1986
    Date of Patent: May 24, 1988
    Assignee: E. I. DuPont de Nemours and Company
    Inventors: Joseph L. Glajch, Joseph J. Kirkland
  • Patent number: 4705725
    Abstract: This invention relates to unique stable support structures comprising substrates coated with sterically-protecting monofunctional silanes. This structure consists of an appropriate reactive solid to which a monofunctional silane is covalently bonded that contains at least two sterically-protecting groups attached to the silicon atom of the silane.
    Type: Grant
    Filed: November 28, 1986
    Date of Patent: November 10, 1987
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Joseph L. Glajch, Joseph J. Kirkland